Healthcare & Life Sciences
Petra Pharma
United States
acquiredacquired
acquired
Stage
1
Investors
About
Petra Pharma develops novel therapeutics targeting phosphoinositide (PI) signaling pathways for the treatment of cancer and other serious diseases.
Explore Petra Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.